Calcium/Calmodulin-Dependent Protein Kinase is Involved in the Release of High Mobility Group Box 1 Via the Interferon-β Signaling Pathway
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Previously, we have reported that high mobility group box 1(HMGB1), a proinflammatory mediator in sepsis, is released via the IFN-β-mediated JAK/STAT pathway. However, detailed mechanisms are still unclear. In this study, we dissected upstream signaling pathways of HMGB1 release using various molecular biology methods. Here, we found that calcium/calmodulin-dependent protein kinase (CaM kinase,CaMK) is involved in HMGB1 release by regulating IFN-βproduction. CaMK inhibitor, STO609, treatment inhibits LPS-induced IFN-β production, which is correlated with the phosphorylation of interferon regulatory factor 3 (IRF3). Additionally, we show that CaMK-I plays a major role in IFN-β production although other CaMK members also seem to contribute to this event. Furthermore, the CaMK inhibitor treatment reduced IFN-β production in a murine endotoxemia. Our results suggest CaMKs contribute to HMGB1 release by enhancing IFN-β production in sepsis.
Abstract
Previously, we have reported that high mobility group box 1(HMGB1), a proinflammatory mediator in sepsis, is released via the IFN-β-mediated JAK/STAT pathway. However, detailed mechanisms are still unclear. In this study, we dissected upstream signaling pathways of HMGB1 release using various molecular biology methods. Here, we found that calcium/calmodulin-dependent protein kinase (CaM kinase,CaMK) is involved in HMGB1 release by regulating IFN-βproduction. CaMK inhibitor, STO609, treatment inhibits LPS-induced IFN-β production, which is correlated with the phosphorylation of interferon regulatory factor 3 (IRF3). Additionally, we show that CaMK-I plays a major role in IFN-β production although other CaMK members also seem to contribute to this event. Furthermore, the CaMK inhibitor treatment reduced IFN-β production in a murine endotoxemia. Our results suggest CaMKs contribute to HMGB1 release by enhancing IFN-β production in sepsis.
참고문헌 (16)
- Sims, G. P, "HMGB1 and RAGE in inflammation and cancer", Annu. Rev. Immunol, 28, pp.367~388 (2010)
- Lotze, M. T, "High-mobility group box1 protein (HMGB1): nuclear weapon in the immune arsenal", Nat. Rev. Immunol, 5, pp.331~342 (2005)
- Degryse, B., "The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells", J. Cell Biol, 152, pp.1197~1206 (2001)
- Rouhiainen, A., "Regulation of monocyte migration by amphoterin", Blood, 104, pp.1174~1182 (2004)
- Sappington, P. L., "HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice", Gastroenterology, 123, pp.790~802 (2002)
- Andersson, U., "High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes", J. Exp. Med, 192, pp.565~570 (2000)
- 신전수, "High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes", Journal Of Immunology, 180, pp.5067~5074
- Sha, Y., "HMGB1 develops enhanced proinflammatory activity by binding to cytokines", J. Immunol, 180, pp.2531~2537 (2008)
- Bonaldi, T., "Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion", EMBO J, 22, pp.5551~5560 (2003)
- Kim, J. H., "Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway", J. Immunol, 182, pp.2458~2466 (2009)
- Zhang, X., "Calcium", calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages, 2008, pp.181, 5015~5023
- Wang, L., "'Tuning' of type I interferon-induced Jak- STAT1 signaling by calcium-dependent kinases in macrophages", Nat. Immunol, 9, pp.186~193 (2008)
- Tokumitsu, H., "STO-609, a specific inhibitor of the Ca(2+)", calmodulin-dependent protein kinase kinase, 2002, pp.277, 15813~15818
- Karaghiosoff, M., "Central role for type I interferons and Tyk2 in lipopolysaccharide- induced endotoxin shock", Nat. Immunol, 4, pp.471~477 (2003)
- Weighardt, H., "Type I IFN modulates host defense and late hyperinflammation in septic peritonitis", J. Immunol, 177, pp.5623~5630 (2006)
- Liu, X., "CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages", Blood, 112, pp.4961~4970 (2008)